1. 2-ethylamino-6-chloro-4-methyl-4-phenyl-4h-3,1-benzoxazine
2. Etafenoxine
3. Etafenoxine Hydrochloride
4. Etifoxin
5. Etifoxine
6. Hoe 36801
7. Stresam
1. 56776-32-0
2. Etifoxine Hcl
3. Etifoxine (hydrochloride)
4. Stresam
5. 6-chloro-n-ethyl-4-methyl-4-phenyl-4h-3,1-benzoxazin-2-amine Monohydrochloride
6. Nbl8010wh5
7. Hoe 36-801 (hydrochloride)
8. Etifoxin
9. 6-chloro-2-n-ethyl-4-methyl-4-phenyl-4h-3,1-benzoxazin-2-amine Hydrochloride
10. 6-chloro-n-ethyl-4-methyl-4-phenyl-3,1-benzoxazin-2-amine;hydrochloride
11. Unii-nbl8010wh5
12. Einecs 260-380-0
13. Stresam (tn)
14. Hoe-36801 Hydrochloride
15. Mls006010668
16. Schembl547700
17. Dtxsid50972228
18. Hoe-36-801
19. Bcp20603
20. Etifoxine Hydrochloride [mi]
21. 6-chloro-n-ethyl-4-methyl-4-phenyl-3,1-benzoxazin-2-amine Hydrochloride
22. Akos024457433
23. Cs-1103
24. Etifoxine Hydrochloride [mart.]
25. Etifoxine Hydrochloride [who-dd]
26. Bs-17088
27. Etifoxine Hydrochloride, >=98% (hplc)
28. Hy-16579
29. Smr002529561
30. Ft-0668419
31. D07930
32. Hoe 36-801 Hydrochloridehoe 36-801 Hydrochloride
33. Q27284779
34. 6-chloro-n-ethyl-4-methyl-4-phenyl-4h-3,1-benzoxazin-2-amine Hcl
35. 4h-3,1-benzoxazin-2-amine, 6-chloro-n-ethyl-4-methyl-4-phenyl-, Monohydrochloride
36. 6-chloro-n-ethyl-4-methyl-4-phenyl-1h-3,1-benzoxazin-2-imine;hydrochloride
37. 6-chloro-n-ethyl-4-methyl-4-phenyl-1,4-dihydro-2h-3,1-benzoxazin-2-imine--hydrogen Chloride (1/1)
Molecular Weight | 337.2 g/mol |
---|---|
Molecular Formula | C17H18Cl2N2O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 336.0796186 g/mol |
Monoisotopic Mass | 336.0796186 g/mol |
Topological Polar Surface Area | 33.6 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 394 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
LOOKING FOR A SUPPLIER?